Correlation between apoptosis-, proliferation and bcl-2 expression in malignant non-Hodgkin's lymphoma

Journal of Clinical Pathology - Clinical Molecular Pathology

Volumn 49, Issue 5, 1996, Pages

  Kiberu, S W ^a   Pringle, J H ^a   Sobolewski, S ^a   Murphy, P ^a   Lander I ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

Bcl 2; Grade; Non Hodgkin's lymphoma, apoptosis; Proliferation

Indexed keywords

HISTONE; MESSENGER RNA; PROTEIN BCL 2;

APOPTOSIS; ARTICLE; CELL PROLIFERATION; CLINICAL ARTICLE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL;

EID: 0029847287     PISSN: 13552910     EISSN: None     Source Type: Journal    
DOI: 10.1136/mp.49.5.m268     Document Type: Article

References (20)

1. Hall P, Levinson D, Wright NA. Assessment of cell proliferation in clinical practice. Berlin: Springer Verlag, 1992:45-62.
2. Gavrieli Y, Herman Y, Bensasson SA. Identification of programmed cell death via specific labelling of nuclear DNA fragmentation. J Cell Biol 1992; 119:493-501.
3. Leoncini L, Del Vecchio MT, Megha T, Barbini P, Galieni P, Piled S, et al. Correlations between apoptotic and proliferative indices in malignant and non-malignant lymphomas. AmJPathol 1993;142:755-63.
4. Quinn CM, Wright NA. The clinical assessment of proliferation and growth in human tumours: evaluation of methods and applications as prognostic variables. J Pathol 1990;160:93-102.
5. Wright NA, Alison MR. The biology of epithelial cell populations. Oxford: Oxford University Press, 1984.
6. Gratzner HG. Monoclonal antibody to 5-bromo and 5-iododeoxyuridine: a new reagent for detection of DNA replication. Science 1982;218:474-5.
7. Schmperli D. Cell-cycle regulation of histone gene expression. Cell 1986;42:471-2.
8. Malcolm A, Chaudry Z, Lauder I, Pringle JH. Liver regeneration: a comparison of in situ hybridization for histone mRNA with bromodeoxyuridine labeling for the detection of S-phase cells. J Histochem Cytochem 1994;42: 1603-8.
9. Tsujimoto Y, Finger LP, Yunis J, Nowell PL, Roe CM. Cloning of the chromosome breakpoint of neoplastic B cells with the t(14:18) chromosomal translocation. Science 1984;226:1097-9.
10. Bakhshi A, Jensen JP, Goldman P, Wright JJ, McBride OW, Epstein AL, et al. Cloning the chromosomal breakpoint of (14:18) human lymphomas: clustering around JH on chromosome 14 and near a transcriptional unit on 18. Cell 1985;41:899-906.
11. Zuther M, Hockenbery D, Gary A, Korsmeyer SJ. Immunolocalisation of the bcl-2 protein within haemopoietic neoplasms. Blood 1991;78:1062-8.
12. Hockenbery, Nunez D, Millman C, Schreiber D, Korsmeyer SJ. BCL-2 is an inner mitocondrial membrane protein that blocks programmed cell death. Nature 1990;348:334-6.
13. Korsmeyer SJ. Bcl-2 initiates a new category of oncogenes: regulators of cell death. Blood 1992;80:879-86.
14. Cattoretty G, Pilleri S, Parravicini C, Becker MHG, Poggi S, Bifulco C, et al. Antigen unmasking on formalin fixed and paraffin embedded tissue sections. J Pathol 1993;171: 83-98.
15. Brandtzaeg P. Tissue preparation methods for immunocytochemistry. In: Bulloch GR, Perusz P, eds. Techniques in immunocytochemistry. London: Academic Press 1982: 2-75.
16. Ansari B, Coates PS, Greenstein BD, Hall PA. In situ end labelling DNA strand breaks in apoptosis and pathological slates. J Pathol 1993;170:1-8.
17. Lauder I, Hebshaw JA (eds). Malignant lymphomas. 1988: 1-21.
18. Del Vecchio MT, Leoncini L, Buerki K, Kraft R, Megha T, Barbini P, et al. Diffuse centrocytic and/or centroblastic malignant non-Hodgkin's lymphomas: comparison of mitotic and pyknotic (apoptotic) indices. Int J Cancer 1991;47:38-43.
19. Mingqing D, Nalini S, Aziz H, Isaacson PG, Langxing P. Positive correlation between apoptotic and proliferative indices in gastrointestinal lymphomas of mucosaassociated lymphoid tissue (MALT). J Pathol 1996;178: 379-84.
20. Hermine O, Haioun C, Lepage E, d'Agay MF, Briere J, Lavignac C, et al. Prognostic significance of bcl-2 protein expression in aggressive non-Hodgkin's lymphoma. Blood 1996;87:265-72.